Department of Palliative Medicine, Poznan University of Medical Sciences, Poznan, Poland.
Clin Interv Aging. 2020 Apr 28;15:583-594. doi: 10.2147/CIA.S250508. eCollection 2020.
Older adults should be routinely screened for sarcopenia, which threatens healthy, independent aging. The most popular screening tool is the SARC-F questionnaire. As its sensitivity is unsatisfactory, two modified versions of the questionnaire have been published: SARC-CalF (including calf circumference as an additional item) and SARC-F+EBM (assessing additionally age and Body Mass Index). The diagnostic performance of the three versions of the questionnaire has not been compared. The analysis aimed to assess the diagnostic value of SARC-F, SARC-CalF, and SARC-F+EBM questionnaires, and to compare their psychometric properties against two reference standards of sarcopenia diagnosis, ie, EWGSOP1 and modified EWGSOP2 criteria.
We performed the sensitivity/specificity analysis and compared the overall diagnostic accuracy of SARC-F, SARC-CalF (31cm) (cut-off point 31 cm for both genders), SARC-CalF (33/34cm) (cut-off points: 33 cm for women and 34 cm for men), and SARC-F+EBM in 115 community-dwelling volunteers aged ≥ 65 yrs from Poland.
Depending on the version of the SARC-F questionnaire used, from 10.4% [SARC-CalF (31cm)] to 33.0% (SARC-F+EBM) were identified as having an increased risk of sarcopenia. Sarcopenia was identified in 17.4% by the EWGSOP1 criteria and in 13.9% by the modified EWGSOP2 criteria. With respect to the two reference standards used, the sensitivity of SARC-F, SARC-CalF (31cm), SARC-CalF (33/34cm), and SARC-F+EBM ranged 30.0-37.5%, 35.0-37.5%, 60.0-62.5%, 55.0% (the same value for both reference standards), respectively. The specificity ranged 85.3-85.9%, 93.9-94.7%, 88.4-86.9%, 70.7-71.6%, respectively. The AUC of SARC-F, SARC-CalF (31cm), SARC-CalF (33/34cm) and SARC-F+EBM ranged 0.644-0.693, 0.737-0.783, 0.767-0.804, 0.714-0.715, respectively.
The modified versions of SARC-F have better diagnostic performance as compared to the original questionnaire. Since an ideal screening tool should have reasonably high sensitivity and specificity, and an AUC value above 0.7, the SARC-CalF (33/34cm) seems to be the best screening tool for sarcopenia in community-dwelling older adults.
老年人应定期进行肌少症筛查,这会威胁到健康、独立的老龄化。最流行的筛查工具是 SARC-F 问卷。由于其敏感性不令人满意,因此已经发布了两种经过修改的问卷版本:SARC-CalF(包含小腿围度作为附加项目)和 SARC-F+EBM(评估年龄和体重指数)。这三种版本的问卷的诊断性能尚未进行比较。该分析旨在评估 SARC-F、SARC-CalF 和 SARC-F+EBM 问卷的诊断价值,并比较它们的心理测量特性与肌少症诊断的两个参考标准,即 EWGSOP1 和修改后的 EWGSOP2 标准。
我们对 SARC-F、SARC-CalF(31cm)(男女均为 31cm 作为截断点)、SARC-CalF(33/34cm)(女性截断点为 33cm,男性为 34cm)和 SARC-F+EBM 的敏感性/特异性进行了分析,并在 115 名来自波兰的≥65 岁的社区居住志愿者中比较了它们的整体诊断准确性。
根据使用的 SARC-F 问卷版本,从 10.4%(SARC-CalF(31cm))到 33.0%(SARC-F+EBM)被确定为存在肌少症风险增加。EWGSOP1 标准识别出 17.4%的肌少症,修改后的 EWGSOP2 标准识别出 13.9%的肌少症。使用两种参考标准,SARC-F、SARC-CalF(31cm)、SARC-CalF(33/34cm)和 SARC-F+EBM 的敏感性范围为 30.0-37.5%、35.0-37.5%、60.0-62.5%、55.0%(两个参考标准相同),特异性范围为 85.3-85.9%、93.9-94.7%、88.4-86.9%、70.7-71.6%。SARC-F、SARC-CalF(31cm)、SARC-CalF(33/34cm)和 SARC-F+EBM 的 AUC 值范围为 0.644-0.693、0.737-0.783、0.767-0.804、0.714-0.715。
与原始问卷相比,SARC-F 的修改版本具有更好的诊断性能。由于理想的筛查工具应具有合理的高敏感性和特异性以及 AUC 值大于 0.7,因此 SARC-CalF(33/34cm)似乎是社区居住的老年人肌少症的最佳筛查工具。